Department of Medical Sciences,
Human Genetics Foundation (HuGeF),
Department of Medical Sciences, Human Genetics Foundation (HuGeF)
Silvia Deaglio has not added Biography.
If you are Silvia Deaglio and would like to personalize this page please email our Author Liaison for assistance.
Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
Haematologica Feb, 2002 | Pubmed ID: 11836173
Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells.
Blood Apr, 2002 | Pubmed ID: 11895784
Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk.
Cancer research Apr, 2002 | Pubmed ID: 11956104
Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects.
Breast cancer research and treatment May, 2002 | Pubmed ID: 12083632
Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum.
Blood Nov, 2002 | Pubmed ID: 12393650
Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia.
Blood Apr, 2003 | Pubmed ID: 12456497
Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Mar, 2003 | Pubmed ID: 12551845
Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome?
Haematologica Mar, 2003 | Pubmed ID: 12651280
Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells.
The American journal of pathology Apr, 2003 | Pubmed ID: 12651608
CD38 ligation plays a direct role in the induction of IL-1beta, IL-6, and IL-10 secretion in resting human monocytes.
Cellular immunology Nov, 2002 | Pubmed ID: 12718937
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
Blood Sep, 2003 | Pubmed ID: 12763926
Death of T cell precursors in the human thymus: a role for CD38.
International immunology Sep, 2003 | Pubmed ID: 12917263
Transferrin receptor 2 protein is not expressed in normal erythroid cells.
The Biochemical journal Aug, 2004 | Pubmed ID: 15084147
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
Blood Apr, 2005 | Pubmed ID: 15613544
Immunodetection of anti-MAG IgM antibody by cross-reactivity to LA-N-1 neuroblastoma cells.
Journal of neuroimmunology Apr, 2005 | Pubmed ID: 15748946
CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells.
Blood Mar, 2006 | Pubmed ID: 16293598
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
Blood Aug, 2006 | Pubmed ID: 16621959
TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway.
Journal of cell science Nov, 2006 | Pubmed ID: 17046995
CD38/CD19: a lipid raft-dependent signaling complex in human B cells.
Blood Jun, 2007 | Pubmed ID: 17327405
CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity.
Molecular medicine (Cambridge, Mass.) Nov-Dec, 2006 | Pubmed ID: 17380201
The CD38 ectoenzyme family: advances in basic science and clinical practice.
Molecular medicine (Cambridge, Mass.) Nov-Dec, 2006 | Pubmed ID: 17380202
Transferrin receptor 2 is frequently expressed in human cancer cell lines.
Blood cells, molecules & diseases Jul-Aug, 2007 | Pubmed ID: 17428703
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
The Journal of experimental medicine Jun, 2007 | Pubmed ID: 17502665
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
American journal of hematology Sep, 2007 | Pubmed ID: 17534928
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
Blood Dec, 2007 | Pubmed ID: 17699742
Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.
Haematologica Oct, 2007 | Pubmed ID: 18024373
CD38 at the junction between prognostic marker and therapeutic target.
Trends in molecular medicine May, 2008 | Pubmed ID: 18403265
CD39 and control of cellular immune responses.
Purinergic signalling Mar, 2007 | Pubmed ID: 18404431
The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes.
Purinergic signalling Jun, 2006 | Pubmed ID: 18404481
CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?
Blood Jun, 2008 | Pubmed ID: 18424664
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology.
Physiological reviews Jul, 2008 | Pubmed ID: 18626062
Regulation of transferrin receptor 2 in human cancer cell lines.
Blood cells, molecules & diseases Jan-Feb, 2009 | Pubmed ID: 19019709
CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus.
Molecular medicine (Cambridge, Mass.) Mar-Apr, 2009 | Pubmed ID: 19052657
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
Cancer research May, 2009 | Pubmed ID: 19383907
Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation.
Haematologica Jun, 2009 | Pubmed ID: 19483151
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2009 | Pubmed ID: 19509140
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.
Journal of translational medicine , 2009 | Pubmed ID: 19715592
TfR2 expression in human colon carcinomas.
Blood cells, molecules & diseases Nov-Dec, 2009 | Pubmed ID: 19729324
CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells.
Molecular medicine (Cambridge, Mass.) Mar, 2010 | Pubmed ID: 19956559
Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38.
Haematologica Mar, 2010 | Pubmed ID: 20207849
Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells.
British journal of haematology Jul, 2010 | Pubmed ID: 20346010
Transferrin receptor 2 is frequently and highly expressed in glioblastomas.
Translational oncology Apr, 2010 | Pubmed ID: 20360937
The hidden life of NAD+-consuming ectoenzymes in the endocrine system.
Journal of molecular endocrinology Oct, 2010 | Pubmed ID: 20660167
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.
Hematological oncology Jun, 2011 | Pubmed ID: 20669154
CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells.
Seminars in cancer biology Dec, 2010 | Pubmed ID: 20817095
Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients.
European journal of haematology Dec, 2010 | Pubmed ID: 20846302
Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease.
Leukemia research Mar, 2011 | Pubmed ID: 20880586
Variable impact of CD39 in experimental murine colitis.
Digestive diseases and sciences May, 2011 | Pubmed ID: 20936356
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.
British journal of haematology Feb, 2011 | Pubmed ID: 21121903
Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.
Cell research Oct, 2011 | Pubmed ID: 21403679
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model.
FEBS letters Jun, 2011 | Pubmed ID: 21514298
A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
FEMS immunology and medical microbiology Jul, 2011 | Pubmed ID: 21535228
Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk.
British journal of haematology Jul, 2011 | Pubmed ID: 21554262
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.
Cancer research Jul, 2011 | Pubmed ID: 21565980
Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.
Advances in pharmacology (San Diego, Calif.) , 2011 | Pubmed ID: 21586363
CD38 and chronic lymphocytic leukemia: a decade later.
Blood Sep, 2011 | Pubmed ID: 21765022
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
Blood Nov, 2011 | Pubmed ID: 21881048
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death.
Blood Dec, 2011 | Pubmed ID: 21998208
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.
Blood Dec, 2011 | Pubmed ID: 22039264
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
Blood Jan, 2012 | Pubmed ID: 22077063
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
Haematologica Jun, 2012 | Pubmed ID: 22207686
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
Blood Mar, 2012 | Pubmed ID: 22308293
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.
American journal of hematology Jun, 2012 | Pubmed ID: 22460620
Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy.
Current pharmaceutical design , 2012 | Pubmed ID: 22591383
Different aquaporin-4 expression in glioblastoma multiforme patients with and without seizures.
Molecular medicine (Cambridge, Mass.) , 2012 | Pubmed ID: 22714714
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
The Journal of experimental medicine Aug, 2012 | Pubmed ID: 22891273
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options.
Cancer letters Jan, 2013 | Pubmed ID: 22910767
Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases.
Mediterranean journal of hematology and infectious diseases , 2012 | Pubmed ID: 22973497
Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2012 | Pubmed ID: 23008321
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states.
Journal of molecular medicine (Berlin, Germany) Feb, 2013 | Pubmed ID: 23292173
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
Haematologica Jun, 2013 | Pubmed ID: 23300177
The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.
Haematologica Jul, 2013 | Pubmed ID: 23349302
rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
British journal of haematology Jul, 2013 | Pubmed ID: 23668599
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey.
Leukemia & lymphoma Apr, 2014 | Pubmed ID: 23829282
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia.
Current topics in medicinal chemistry , 2013 | Pubmed ID: 24171772
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.
Haematologica May, 2014 | Pubmed ID: 24362551
Anti-CD44 mAb for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies: evaluation of WO2013063498.
Expert opinion on therapeutic patents Jul, 2014 | Pubmed ID: 24798704
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia.
Blood Jan, 2015 | Pubmed ID: 25368373
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.
Haematologica Feb, 2015 | Pubmed ID: 25398834
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.
Blood Jan, 2016 | Pubmed ID: 26463425
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response.
The Journal of clinical investigation Jan, 2016 | Pubmed ID: 26619119
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death.
Scientific reports , 2016 | Pubmed ID: 27221966
miR-214 and miR-148b targeting inhibits dissemination of melanoma and breast cancer.
Cancer research Jun, 2016 | Pubmed ID: 27328731
The genetics of nodal marginal zone lymphoma.
Blood Jun, 2016 | Pubmed ID: 27335277
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유